Metraipolis › archive › dc_cd31ab9fcef2

JAVEMACS: a real-world study of avelumab maintenance therapy for advanced urothelial carcinoma in Japan — Europe PMC PMID:42568726

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42568726
DOI
10.1016/j.esmorw.2025.100646
License (as archived)
solo-consultazione
Archived
2026-10-07T16:31:47.363Z
SHA-256 of the archived text
9158e84b72c46d9a9a843f0bc82927f466d7641355b9b551cea91ce8459abbfa
Stable URL of this page
https://metraipolis.com/documento/dc_cd31ab9fcef2

How to cite

JAVEMACS: a real-world study of avelumab maintenance therapy for advanced urothelial carcinoma in Japan — Europe PMC PMID:42568726 — Europe PMC (en), https://europepmc.org/article/MED/42568726 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_cd31ab9fcef2 (Metraipolis archive dc_cd31ab9fcef2, sha256 9158e84b72c46d9a9a843f0bc82927f466d7641355b9b551cea91ce8459abbfa)
BibTeX
@misc{dccd31ab9fcef2,
  title = {JAVEMACS: a real-world study of avelumab maintenance therapy for advanced urothelial carcinoma in Japan — Europe PMC PMID:42568726},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42568726},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_cd31ab9fcef2; sha256 9158e84b72c46d9a9a843f0bc82927f466d7641355b9b551cea91ce8459abbfa},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42568726. Agents can read the archived copy with the MCP tool read_document.